<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8"/>
    <meta property="og:url" content="https://www.business-standard.com/article/companies/sun-pharma-britain-s-astrazeneca-join-to-distribute-cancer-drugs-in-china-119110600174_1.html"/>
    <meta property="og:site_name" content="Business-Standard"/>
    <meta property="article:published_time" content="2019-11-06T03:27:00+00:00"/>
    <meta property="og:title" content="Sun Pharma, Britain's AstraZeneca join to distribute cancer drugs in China"/>
    <meta property="og:description" content="The financial terms of the agreement, which has an initial tenure of 10 years, were not disclosed"/>
  </head>
  <body>
    <article>
      <h1>Sun Pharma, Britain's AstraZeneca join to distribute cancer drugs in China</h1>
      <h2>The financial terms of the agreement, which has an initial tenure of 10 years, were not disclosed</h2>
      <address><time datetime="2019-11-06T03:27:00+00:00">06 Nov 2019, 03:27</time> by <a rel="author">Reuters</a></address>
      <p>Indian drugmaker <a href="https://www.business-standard.com/topic/sun-pharmaceutical-industries">Sun Pharmaceutical Industries </a>Ltd said on Wednesday it would introduce some of its cancer treatment drugs in China through Britain's <a href="https://www.business-standard.com/topic/astrazeneca">AstraZeneca.</a></p>
      <p>This comes after <a href="https://www.business-standard.com/topic/astrazeneca">AstraZeneca </a>said it was launching a new fund with China International Capital Corp to invest $1 billion in China's healthcare sector, as it expands its research work in the country.</p>
      <p><a href="https://www.business-standard.com/topic/sun-pharma">Sun Pharma </a>will be responsible for development, regulatory filings and manufacturing of the drugs covered in the deal, while <a href="https://www.business-standard.com/topic/astrazeneca">AstraZeneca </a>will exclusively promote and distribute the products in China, according to a <a href="https://www.bseindia.com/xml-data/corpfiling/AttachLive/e10d3bee-3ab1-4a0f-ab45-600f16796260.pdf">filing</a> to Indian stock</p>
      <p>The financial terms of the agreement, which has an initial tenure of 10 years, were not disclosed.</p>
    </article>
  </body>
</html>